Global Anticonvulsants Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers

1 Aug, 2023

The global anticonvulsants market size is expected to grow from $17.65 billion in 2022 to $18.39 billion in 2023 at a compound annual growth rate (CAGR) of 4.22%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global anticonvulsants market size is expected to reach $20.87 billion in 2027 at a CAGR of 3.2%.

Global Anticonvulsants Market Key Driver

The rising prevalence of epilepsy is likely to drive future growth in the anticonvulsant industry. Epilepsy is a common brain illness that commonly results in seizures. It is a chronic, non-transmissible brain disorder that affects people of all ages. Anticonvulsants are drugs that are used to treat seizures in persons who have epilepsy. Anticonvulsants help control epilepsy symptoms by inhibiting the aberrant electrical activity in the brain that produces seizures, but they are not a solution for the disease.

Get a sample of the global anticonvulsants market report

Global Anticonvulsants Market Segments

The global anticonvulsants market is segmented:
1) By Type: Pyrimidinediones, Benzodiazepines, Fructose Derivatives, Aromatic Allylic Alcohols, Valproylamides, Carboxamides, Bromides, Other Types
2) By Drug Generation: First Generation, Second Generation, Third Generation
3) By Dosage: Capsule, Tablet, Cream, Liquid, Rectal Gel, Other Dosages
4) By Application: Migraine, Epilepsy, Neuropathic Pain, Anxiety, Fibromyalgia, Bipolar Disorder, Borderline Personality Disorder
5) By End-User: Hospitals, Clinics, Other End-Users
6) By Geography: The regions covered in the anticonvulsants market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global anticonvulsants market.

Major Anticonvulsants Industry Players

Eisai Co Ltd., GSK plc, Pfizer Inc., Johnson & Johnson Services Inc ., Novartis AG, Jazz Pharmaceuticals Inc., UCB SA, Teva Pharmaceutical Industries Ltd., Sunovion Pharmaceuticals Inc., Sanofi SA, Zydus Lifesciences Ltd., Lupin Limited, Ratiopharm, Kannalife Inc., Neuropathix Inc.

Get the full global anticonvulsants market report

Anticonvulsants Market Overview

Anticonvulsants, also called anti-seizure medication and antiepileptics, refer to a type of drug or medication used to prevent and treat seizures or convulsions by controlling abnormal electrical activity in the brain. This medication is used to treat conditions such as nerve pain and restless leg syndrome.

Anticonvulsants Global Market Report 2023 provides data on the global anticonvulsants market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The anticonvulsants market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.